Yaso Gel (PPCM)

About Yaso Therapeutics

Yaso Therapeutics is pioneering a nanotechnology-enabled therapeutic platform centered on its patented polymer, Polyphenylene Carboxymethylene (PPCM). The company's lead product candidate, Yaso Gel, is positioned as a non-hormonal, multipurpose prevention technology (MPT) designed for contraception and protection against viral and bacterial pathogens, including drug-resistant strains. Currently in Phase 1 clinical testing for contraception, the platform has demonstrated broad-spectrum in vitro activity against pathogens like HIV, HSV, HPV, SARS-CoV-2, and gonorrhea. Yaso's mission is to address significant unmet needs in global family planning and sexual health by offering a potentially safer, more tolerable, and scalable alternative to existing hormonal contraceptives and prophylactics.

About Yaso Therapeutics

Yaso Therapeutics is pioneering a nanotechnology-enabled therapeutic platform centered on its patented polymer, Polyphenylene Carboxymethylene (PPCM). The company's lead product candidate, Yaso Gel, is positioned as a non-hormonal, multipurpose prevention technology (MPT) designed for contraception and protection against viral and bacterial pathogens, including drug-resistant strains. Currently in Phase 1 clinical testing for contraception, the platform has demonstrated broad-spectrum in vitro activity against pathogens like HIV, HSV, HPV, SARS-CoV-2, and gonorrhea. Yaso's mission is to address significant unmet needs in global family planning and sexual health by offering a potentially safer, more tolerable, and scalable alternative to existing hormonal contraceptives and prophylactics.

Therapeutic Areas